Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.02 | 1.68 |
NAV | ₹13.89 | ₹210.65 |
Fund Started | 16 Aug 2022 | 20 Aug 2004 |
Fund Size | ₹2074.60 Cr | ₹15641.91 Cr |
Exit Load | Exit Load for units in excess of 25% of the investment,1% will be charged for redemption within 365 days. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 11.16% | 18.24% |
3 Year | - | 21.56% |
5 Year | - | 23.41% |
1 Year
3 Year
5 Year
Equity | 97.98% | 83.08% |
Cash | 2.02% | 16.60% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 8.00% |
ICICI Bank Ltd. | 7.11% |
Infosys Ltd. | 4.55% |
Reliance Industries Ltd. | 4.00% |
Larsen & Toubro Ltd. | 3.52% |
Bharti Airtel Ltd. | 3.27% |
Sun Pharmaceutical Industries Ltd. | 2.77% |
State Bank of India | 2.74% |
Interglobe Aviation Ltd. | 2.39% |
Tata Consultancy Services Ltd. | 2.32% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.29% |
ICICI Bank Ltd. | 9.01% |
Axis Bank Ltd. | 8.44% |
Maruti Suzuki India Ltd. | 4.34% |
Cipla Ltd. | 4.11% |
SBI Life Insurance Company Ltd. | 4.00% |
Kotak Mahindra Bank Ltd. | 4.00% |
HCL Technologies Ltd. | 3.80% |
Piramal Pharma Ltd. | 3.57% |
Bharti Airtel Ltd. | 3.55% |
Name | Dwijendra Srivastava | Dhruv Muchhal |
Start Date | 03 Nov 2015 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate capital appreciation by dynamically investing in a mix of equity and equity related instruments across market capitalization. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 16 Aug 2022 | 20 Aug 2004 |
Description
Launch Date